BTX-A

Swiss trademark · 502469 · Word mark · Deleted

Register entry

Registration number
502469
Application number
04971/2002
Status
Deleted
Type
Word mark
Filed
Jun 4, 2002
Registered
Aug 22, 2002
Published
Sep 5, 2002
Deleted
Dec 31, 2022
Reason
Not renewed
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Behandlung von neurologisch bedingten Bewegungsstörungen, Dystonien, Störungen der glatten Muskulatur, Störungen des autonomen Nervensystems, Kopfschmerzen, Falten, Hyperhydrose, Sportverletzungen, Zerebralparese, Krämpfe, Tremor, Muskelschmerzen, Miktionsstörungen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 31, 2022

    Deleted, not renewed

    Published in Swissreg on 31.12.2022

  2. Apr 16, 2014

    Agent’s address changed

    Representative
    A.W. Metz & Co. AG, Hottingerstrasse 14, 8024 Zürich → A.W. Metz & Co. AG, Kreuzbühlstrasse 8, 8008 Zürich

    Published in Swissreg on 16.04.2014

  3. Feb 1, 2012

    Renewed

    Published in Swissreg on 01.02.2012

  4. Sep 5, 2002

    Registered

    Published in the SOGC no. 171 of 05.09.2002

Parties

Holder

Allergan, Inc. A Delaware Corporation

2525 Dupont Drive, Irvine (CA 92612), US

Agent

A. W. Metz & Co. AG in Liquidation

A.W. Metz & Co. AG

Kreuzbühlstrasse 8, 8008 Zürich

In liquidation

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.